Literature DB >> 25424980

Evaluation of Speak for Myself with Patients Who Are Voiceless.

Rebecca S Koszalinski1, Ruth M Tappen1, David Viggiano2.   

Abstract

PURPOSE: To describe the creation and initial feasibility study of a new computer application to improve communication with people who cannot communicate by customary means during their hospitalization.
DESIGN: This was a mixed-methods, quasi-experimental design.
METHODS: This exploratory feasibility study obtained data about the experiences of 20 intensive care patients in three South Florida hospitals who were unable to speak due to mechanical obstruction.
FINDINGS: Study participants (20), who ranged in age from 45 to 91 years (M=67.4, SD=12.88) and between -1 to +1 (SD=-0.15) on the Richmond Agitation Sedation Scale, used Speak for Myself from 4 to 16 hours with a mean of 8.86 (SD=2.12). Ninety-five percent of the participants stated that Speak for Myself was helpful for communication.
CONCLUSIONS: Speak for Myself was helpful to patients who used it. This was a small study (n=20). It warrants further investigation. CLINICAL RELEVANCE: Patients who are unable to communicate their needs through conventional methods still want to make their preferences and needs known. Speak for Myself is a new application that facilitates ensuring the patient's voice is heard.
© 2014 Association of Rehabilitation Nurses.

Entities:  

Keywords:  Communication; Speak for Myself; patient autonomy; patient voice

Mesh:

Year:  2014        PMID: 25424980     DOI: 10.1002/rnj.186

Source DB:  PubMed          Journal:  Rehabil Nurs        ISSN: 0278-4807            Impact factor:   1.625


  2 in total

1.  Communication with invasive mechanically ventilated patients and the use of alternative devices: integrative review.

Authors:  Aziza Salem; Muayyad M Ahmad
Journal:  J Res Nurs       Date:  2018-07-24

Review 2.  Communicating with conscious and mechanically ventilated critically ill patients: a systematic review.

Authors:  S Ten Hoorn; P W Elbers; A R Girbes; P R Tuinman
Journal:  Crit Care       Date:  2016-10-19       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.